Company profile

Nvelop Therapeutics

Unlocking the full potential of genetic medicines.

Industry
Biotechnology Research
Employees
3
Headquarters
Cambridge, Massachusetts
Founded
2022
LinkedIn followers
8,421
Office locations
1

Nvelop Therapeutics company summary

Nvelop Therapeutics is a company in the Biotechnology Research industry, headquartered in Cambridge, Massachusetts, founded in 2022. On LinkedIn the company has around 3 employees and 8,421 followers.

What technology does Nvelop Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Nvelop Therapeutics

At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization to support this important mission, bringing together individuals that thrive in a supportive environment where diverse perspectives and a passion for discovery drive cutting-edge science and breakthrough medicines. Read something that resonates? Reach out to careers@NvelopTx.com.

Where is Nvelop Therapeutics located?

Nvelop Therapeutics lists 1 location.

Cambridge, Massachusetts, USHQ
100 Technology Square

Compare companies similar to Nvelop Therapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Nvelop Therapeutics
nveloptx.com
Biotechnology Research32022Cambridge, Massachusetts
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Nvelop Therapeutics

What does Nvelop Therapeutics do?

At Nvelop, we are working to address the complex challenge of effectively delivering genetic medicines to target cells within the body (in vivo) in order to help treat patients with previously undruggable diseases. Our team is advancing two next-generation delivery platforms, started in the labs of our scientific co-founders Dr. David Liu of the Broad Institute of MIT and Harvard, and Dr. Keith Joung formerly of Mass General Hospital. We will use these platforms to build a pipeline of therapeutics internally and to enable strategic partners. We are building a culture and organization to support this important mission, bringing together individuals that thrive in a supportive environment where diverse perspectives and a passion for discovery drive cutting-edge science and breakthrough medicines. Read something that resonates? Reach out to careers@NvelopTx.com.

How many employees does Nvelop Therapeutics have?

Nvelop Therapeutics has around 3 employees on LinkedIn.

Where is Nvelop Therapeutics headquartered?

Nvelop Therapeutics is headquartered in Cambridge, Massachusetts.

When was Nvelop Therapeutics founded?

Nvelop Therapeutics was founded in 2022.

Build a lead list from companies like Nvelop Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.